GEMMA project deliverables
The page lists 9 deliverables related to the research project "GEMMA".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
OmnomicsNGS v2 releaseA new relase of the software OmnomicsNGS including a tool for dynamic variant analysis and interpretation Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Demonstrators, pilots, prototypes | 2020-04-25 |
Genome, epigenome and immune function interplay summary of hypothesisAn hypothesis regarding how the genome/metagenome interplay is responsible for the switch from immune tolerance to immune response to environmental stimuli (antigens) including dietary and microbial factors leading to neuroinflammation responsible of behavioural changes that characterize ASD and gut inflammation causing its GI co-morbidities Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
Pre-clinical study ethical approval reportA study protocol to submit for the approbation to the ethical committee Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
Updated state of the art reportReport providing a brief relation about the state of the art in the ASD biomarker and therapy Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
Microbiome, metabolome and immune function interplay summary of hypothesisAn hypothesis regarding how the gut bacterial dysbiosis leads to epigenetic modifications, changes in metabolic profiles, increased gut permeability, increased antigen trafficking and, ultimately to altered immune responses to promote disease in a subset of individuals at-risk of ASD Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
Pre-clinical study 3/1 reportA first report providing the results of trial 3 to establish whether correction of dysbiosis by pre/pro/symbiotic intervention prevents and/or treats increased the impaired gut permeability, changes in metabolic profile, modification of the immune response, and, ultimately, the onset of ASD behavioural symptoms in humanized murine models of ASD (mice transplanted with faecal bacterial content of ASD patient donor sample Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
External project websiteProject website: project description, public deliverables, scientific news, other Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Websites, patent fillings, videos etc. | 2020-04-25 |
Final clinical protocolsStudy protocols to submit for the approbation to the ethical committee Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Documents, reports | 2020-04-25 |
Open data management planGEMMA participation on H2020 open data pilot Programme: H2020-EU.3.1.2. - Topic(s): SC1-BHC-03-2018 |
Open Research Data Pilot | 2020-04-25 |